The Importance of Blastocyst Diamater and Its Correlation to Reproductive Outcomes in PGT-A Cases
NCT ID: NCT05499988
Last Updated: 2022-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2022-08-07
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation and Diagnosis of the Chromosome Variation in Donated/abandoned Blastocyst
NCT05216068
RCT Study to Validate niPGT-A Clinical Benefit.
NCT04000152
Idealizing Pregnancy Outcome With Single Blastocyst Transfer in a FET Cycle
NCT01987856
Study of the Best Blastocyst Post Transfer by aCGH
NCT01664546
PGT-A Versus Blastocyst Morphology Selection
NCT03095053
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to evaluate the importance of blastocyst diameter in PGT-A cases, measurements will be taken on the day of trophoectoderm biopsy TE (diameter in μm), followed by TE biopsy using flicking technique. Next, PGT-A will be done using NGS platform and results will be confirmed using PGT-ai. Thawing of euploid blastocyst will take place and expansion degree, survival rate will be recorded. Patient will be followed up for the clinical pregnancy and implantation rates.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male aged 18-60 years old
* ICSI cases having PGT-A for their blastocysts
* Must have their blastocysts cultured in time lapse incubator
Exclusion Criteria
* Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
* Use of donor oocytes or sperm
* Use of gestational carrier
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ganin Fertility Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman Hasanen
Embryologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eman Hasanen, BSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Manar Hozayen, MSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Amr Elshimy, BSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Hanaa Alkhader
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Hosam Zaki, MSc, FRCOG
Role: STUDY_DIRECTOR
Ganin Fertility Center
Samar Gamal, BP
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ganin Fertility Center
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFC-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.